Reference Material Choice Affects LC-MS/MS Infliximab Quantitation
Open Access
- 28 May 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 11 (5) , 1278-1281
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround timeJournal of Mass Spectrometry and Advances in the Clinical Lab, 2024
- An automated mass spectrometric blood test for therapeutic drug monitoring of infliximabClinical Mass Spectrometry, 2019
- The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activitymAbs, 2018
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel DiseaseGastroenterology, 2017
- Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC–MS/MSInternational Immunopharmacology, 2015